Helping our patient communities and advancing knowledge in our therapy areas is part of our corporate responsibility.
It is our mission to discover, develop, and deliver innovative therapies that improve patients' quality of life.
We work with government authorities to ensure patients have access to care while also funding medical research.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
A clinical trial is a research study that is done to find out if medical treatments can improve people’s health.
Every day at CSL Behring, we work as if someone’s life depends on it, because it does.
CSL Behring biotherapies are manufactured in state-of-the-art facilities under stringent, controlled conditions.
Help us deliver on our promise to save lives and protect the health of people.
Make your well-being a priority. It's important and so are you.
Learning she had the rare genetic disease Alpha 1 led Julie MacNeil to find her birth family.
Despite setbacks, Jonathan Maidment didn’t give up - and raised $60,000 for the rare disease.
CSL Behring employees ride with Alpha-1 Foundation Team for Escape to the Cape.
Karen Skålvoll joins a cast of fierce female competitors in Grrrl campaign.
Some cleaning products can cause or worsen respiratory problems for those with genetic lung conditions.
Meet an Alpha 1 patient who advocates for others with the rare disease
Patient advocates share stories to empower others living with similar conditions.
Talking to a fellow patient can make the newly-diagnosed feel less isolated.
Frank Willersinn discovered he had Alpha-1 and then became a vocal advocate.
See Alpha-1 patient Dee's tips for those just diagnosed with this rare disease.
With feats of strength, Karen Skålvoll puts her rare lung disease in its place.
Arran Strong rides the waves to raise awareness about respiratory diseases
Popular search terms:
Americas
Asia Pacific
Europe
